Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support)

NCT04348513 is registered in ClinicalTrials.gov with Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. as lead sponsor.

NCT NCT04348513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection (Thy-Support)
Lead sponsor
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Phase
Phase 2
Overall status
Terminated
Start date
May 29, 2020
Completion date
April 19, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, pulmonary infection